Correction: Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

机译：矫正：心房颤动患者血压控制和中风或全身栓塞的风险：中风血管和室心房颤动（亚里士多德）试验中的中风和其他血栓栓塞事件的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

(J Am Heart Assoc. 2021;10:e014653. DOI: 10.1161/JAHA.119.014653.) [PMC free article] [PubMed] [CrossRef] [Google Scholar]

机译：（J AM Heart Acap。2021; 10：E014653。DOI：10.1161 / Jaha.119.014653。）[PMC免费文章] [Pubmed] [CrossRef] [Google Scholar]

著录项

期刊名称 Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
作者

展开▼
作者单位

展开▼
年(卷),期 2021(10),4
年度 2021
页码 e014653
总页数 1
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
入库时间 2022-08-21 12:01:02

相似文献

外文文献
中文文献
专利

1. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [J] . Basil S. Lewis, Bernard J. Gersh, Cetin Erol, Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease . 2015,第4期

机译：房颤患者的血压控制和中风或全身性栓塞的风险：阿哌沙班减少房颤的卒中和其他血栓栓塞事件的结果（ARISTOTLE）
2. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: A subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial [J] . GotoS., ZhuJ., LiuL., The American heart journal . 2014,第3期

机译：阿哌沙班与华法林相比在东亚心房颤动患者中预防卒中的疗效和安全性：阿哌沙班在减少房颤和其他血栓栓塞事件中的亚分析（ARISTOTLE）
3. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: A subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial [J] . GotoS., ZhuJ., LiuL., The American heart journal . 2014,第3期

机译：亚西仙素对东亚心房颤动患者中风预防的疗效和安全性：中颌骨纤维化的细胞分析和心房颤动（亚里士多德）试验中的卒中和其他血栓栓塞事件
4. Incidence of Atrial Fibrillation After Percutaneous Closure of Patent Foramen Ovale and Small Atrial Septal Defects in Patients Presenting with Cryptogenic Stroke: A Case-Control Study [C] . R.F. Bonvini, R. Sztajzel, M. Righini, World Congress on Heart Disease . 2007

机译：用密码脑卒中患者经皮型卵形卵形卵形卵巢经皮和小间隔缺陷后心房颤动的发生率：案例对照研究
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [O] . Meena P. Rao, Sigrun Halvorsen, Daniel Wojdyla, 2015

机译：房颤患者的血压控制和中风或全身性栓塞的风险：阿哌沙班减少房颤的卒中和其他血栓栓塞事件的结果（ARISTOTLE）
7. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation : Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [O] . Rao, Meena P, Halvorsen, Sigrun, Wojdyla, Daniel, 2015

机译：心房颤动患者的血压控制和中风或全身性栓塞的风险：阿哌沙班减少房颤的中风和其他血栓栓塞事件的结果（ARISTOTLE）

Correction: Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

摘要

著录项

相似文献

相关主题

期刊订阅